We are proud that RxAnte has successfully completed our SOC 2 attestation engagement for the second consecutive year, confirming to our clients that we establish and maintain the highest level of security.
Portland, ME. (PRWEB) March 22, 2016
RxAnte, LLC, the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs, today announced it has received its Service Organization Control [SOC] 2 Type II attestation engagement report, providing independent validation that the Company’s security and confidentiality controls meet or exceed the American Institute of Certified Public Accountants (AICPA) guidelines.
The AICPA’s SOC 2 is designed to report on controls that are relevant to the security of the systems used by service organizations to process user entities' data. It can also be used to address the need for assurance on the confidentiality of the information processed by these systems. RxAnte is committed to protecting the healthcare information for millions of patients on behalf of its clients.
"We are proud that RxAnte has successfully completed our SOC 2 attestation engagement for the second consecutive year, confirming to our clients that we establish and maintain the highest level of security,” said Andrew Clearwater, Assistant General Counsel & Privacy Officer of RxAnte. “This accomplishment demonstrates our continued commitment year after year to conform to best practices in the delivery of our growing services. RxAnte will continue to invest in security to ensure our solutions remain backed by sound processes, effective internal controls and the highest standards of security.”
The examination, led by Moody, Famiglietti and Andronico, conducted a thorough review of RxAnte’s policies and practices, focusing on oversight of the organization, vendor management programs, internal corporate governance and risk management processes.
RxAnte is the leading platform for improving medication use and drug therapy outcomes through predictive analytics and targeted clinical programs. Its innovative analytics platform is transforming how organizations work with healthcare professionals, care management intervention providers, and patients to promote the safe and effective use of prescription medications. Created by experts in advanced analytics, medication adherence, health IT, and quality improvement, RxAnte offers patent-pending platforms that include predictive and decision analytics, advanced program evaluation methods, and a web-based work flow solution for health care professionals responsible for improving medication use. Learn more at http://www.rxante.com or follow us on Twitter.